DSIJ Mindshare

CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA

The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share.

DSIJ Intelligence-1 0 76 Article rating: 5.0

The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share.

Multibagger Pharma Stock Under Rs 50 To Be in Focus Today as Company Acquires 100 Per Cent Stake in Cibachem General Trading L.L.C

The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.

DSIJ Intelligence-1 0 452 Article rating: 4.0

The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.

From Rs 5.83 to Rs 29.69 Per Share in Just 11 Months & 10 Days: Multibagger Pharma Stock Hit Upper Circuit for Second Straight Day

The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.

DSIJ Intelligence-1 0 452 Article rating: 3.7

The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share.

RSS
1234567
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR